These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 21921386

  • 21. Hemophagocytic syndrome and neurological involvement in a case of intravascular large B-cell lymphoma.
    Dou L, Wu C, Zeng Z, Zhu J, Su L, Wang T.
    J Int Med Res; 2021 Sep; 49(9):3000605211006644. PubMed ID: 34590922
    [Abstract] [Full Text] [Related]

  • 22. Translocation (14;19)(q32;q13) detected by spectral karyotyping and lack of BCL3 rearrangement in CD5-positive B-cell lymphoma associated with hemophagocytic syndrome.
    Yamamoto K, Nakamura Y, Arai H, Aoyagi M, Saito K, Furusawa S, Mitani K.
    Cancer Genet Cytogenet; 2001 Oct 01; 130(1):38-41. PubMed ID: 11672772
    [Abstract] [Full Text] [Related]

  • 23. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
    Pantelaki I, Tigges C, Nußbaum T, Oellig F, Wieland U, Kreuter A.
    Dermatol Ther; 2017 Jul 01; 30(4):. PubMed ID: 28508527
    [No Abstract] [Full Text] [Related]

  • 24. Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using a 14q telomere probe.
    Kakazu N, Kito K, Hitomi T, Oita J, Nishida K, Masuda K, Miki T, Abe T.
    Am J Hematol; 2000 Dec 01; 65(4):291-7. PubMed ID: 11074557
    [Abstract] [Full Text] [Related]

  • 25. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
    Hashimoto A, Fujimi A, Kanisawa Y, Nakajima C, Hayasaka N, Yamada S, Okuda T, Minami S, Matsumoto T, Shibata T, Hamaguchi K, Kamihara Y, Iwasaki S, Kato J.
    Rinsho Ketsueki; 2015 Jul 01; 56(7):905-10. PubMed ID: 26256929
    [Abstract] [Full Text] [Related]

  • 26. Intermediate lymphocytic lymphoma with both t(14;19)(q32.3;q13.1) and t(3;22)(q27;q11.2).
    Nakagawa M, Sugiyama H, Ogawa H, Tone S, Morishita H, Ikeda H, Aozasa K, Taniwaki M, Abe T, Kishimoto T.
    Cancer Genet Cytogenet; 1995 Jan 01; 79(1):89-91. PubMed ID: 7850761
    [Abstract] [Full Text] [Related]

  • 27. An atypical form of Asian variant of intravascular large B-cell lymphoma presenting with myelopathy alone for 4 months prior to pancytopenia.
    Takizawa S, Shirasugi Y, Nakamura N, Nakagawa S, Tsuchiya T, Ando K, Takagi S.
    Intern Med; 2007 Jan 01; 46(22):1879-80. PubMed ID: 18025772
    [No Abstract] [Full Text] [Related]

  • 28. Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease.
    Kawaji Y, Nagata H, Muramatsu A, Kuriyama K, Ohshiro M, Hirakawa Y, Iwai T, Kobayashi T, Uchiyama H, Urata Y, Kuroda J.
    Ann Hematol; 2019 Jul 01; 98(7):1785-1787. PubMed ID: 31111176
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
    George A, Tam CS, Seymour JF.
    Leuk Lymphoma; 2013 Dec 01; 54(12):2575-6. PubMed ID: 23597141
    [No Abstract] [Full Text] [Related]

  • 33. Targeting the intratumor heterogeneity in PMBL.
    Ritz O, Möller P, Ushmorov A.
    Cell Cycle; 2014 Dec 01; 13(15):2317-8. PubMed ID: 25483178
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Progressive sclerodermoid skin changes--quiz case.
    Dacso MM, Petitt MS, Berlingeri-Ramos AC, Kelly BC.
    Arch Dermatol; 2012 Feb 01; 148(2):247-52. PubMed ID: 22351831
    [No Abstract] [Full Text] [Related]

  • 36. Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
    Landsburg DJ, Falkiewicz MK, Petrich AM, Chu BA, Behdad A, Li S, Medeiros LJ, Cassaday RD, Reddy NM, Bast MA, Vose JM, Kruczek KR, Smith SE, Patel P, Hernandez-Ilizaliturri F, Karmali R, Rajguru S, Yang DT, Maly JJ, Blum KA, Zhao W, Vanslambrouck C, Nabhan C.
    Br J Haematol; 2016 Nov 01; 175(4):631-640. PubMed ID: 27469075
    [Abstract] [Full Text] [Related]

  • 37. t(14;19)(q32;q13): a recurrent translocation in B-cell precursor acute lymphoblastic leukemia.
    Robinson HM, Taylor KE, Jalali GR, Cheung KL, Harrison CJ, Moorman AV.
    Genes Chromosomes Cancer; 2004 Jan 01; 39(1):88-92. PubMed ID: 14603446
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K, Sakai H, Kato M, Nishio Y, Tsuruoka Y, Uemura Y, Yokoi S, Saito T, Matsunawa M, Suzuki Y, Isobe Y, Inoue Y, Takahashi M, Miura I.
    Int J Hematol; 2015 Jun 01; 101(6):608-11. PubMed ID: 25633778
    [Abstract] [Full Text] [Related]

  • 40. CHOP plus rituximab--balancing facts and opinion.
    Cheson BD.
    N Engl J Med; 2002 Jan 24; 346(4):280-2. PubMed ID: 11807154
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.